The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pharmacovigilance Software Market Research Report 2024

Global Pharmacovigilance Software Market Research Report 2024

Publishing Date : Jan, 2024

License Type :

Report Code : 1720363

No of Pages : 88

Ask Your Query

Report Description
Table of Content

Synopsis

It manages all Adverse Events regarding drugs, devices, vaccines, biologics, cosmetics and nutritional supplements.

The global Pharmacovigilance Software market was valued at US$ 171.6 million in 2023 and is anticipated to reach US$ 257.5 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pharmacovigilance Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacovigilance Software.

Report Scope

The Pharmacovigilance Software market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmacovigilance Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmacovigilance Software companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company(Partial List)

United BioSource Corporation
Sparta Systems
Oracle Corporation
Ennov Solutions
Max Application
EXTEDO GmbH
AB Cube
Relsys
Online Business Applications
ArisGlobal

Segment by Type

ADR Reporting
Drug Safety Audits
Issue Tracking
Fully Integrated Software

Segment by Application

Pharma & biotech companies
CROs
BPOs
Others

Consumption by Region

North America (United States, Canada)
Europe (Germany, France, U.K., Italy, Russia)
Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
Latin America (Mexico, Brazil, Argentina)
Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacovigilance Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacovigilance Software Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 ADR Reporting
1.2.3 Drug Safety Audits
1.2.4 Issue Tracking
1.2.5 Fully Integrated Software
1.3 Market by Application
1.3.1 Global Pharmacovigilance Software Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharma & biotech companies
1.3.3 CROs
1.3.4 BPOs
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacovigilance Software Market Perspective (2019-2030)
2.2 Pharmacovigilance Software Growth Trends by Region
2.2.1 Global Pharmacovigilance Software Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmacovigilance Software Historic Market Size by Region (2019-2024)
2.2.3 Pharmacovigilance Software Forecasted Market Size by Region (2025-2030)
2.3 Pharmacovigilance Software Market Dynamics
2.3.1 Pharmacovigilance Software Industry Trends
2.3.2 Pharmacovigilance Software Market Drivers
2.3.3 Pharmacovigilance Software Market Challenges
2.3.4 Pharmacovigilance Software Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacovigilance Software Players by Revenue
3.1.1 Global Top Pharmacovigilance Software Players by Revenue (2019-2024)
3.1.2 Global Pharmacovigilance Software Revenue Market Share by Players (2019-2024)
3.2 Global Pharmacovigilance Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacovigilance Software Revenue
3.4 Global Pharmacovigilance Software Market Concentration Ratio
3.4.1 Global Pharmacovigilance Software Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance Software Revenue in 2023
3.5 Pharmacovigilance Software Key Players Head office and Area Served
3.6 Key Players Pharmacovigilance Software Product Solution and Service
3.7 Date of Enter into Pharmacovigilance Software Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacovigilance Software Breakdown Data by Type
4.1 Global Pharmacovigilance Software Historic Market Size by Type (2019-2024)
4.2 Global Pharmacovigilance Software Forecasted Market Size by Type (2025-2030)
5 Pharmacovigilance Software Breakdown Data by Application
5.1 Global Pharmacovigilance Software Historic Market Size by Application (2019-2024)
5.2 Global Pharmacovigilance Software Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmacovigilance Software Market Size (2019-2030)
6.2 North America Pharmacovigilance Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmacovigilance Software Market Size by Country (2019-2024)
6.4 North America Pharmacovigilance Software Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacovigilance Software Market Size (2019-2030)
7.2 Europe Pharmacovigilance Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmacovigilance Software Market Size by Country (2019-2024)
7.4 Europe Pharmacovigilance Software Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacovigilance Software Market Size (2019-2030)
8.2 Asia-Pacific Pharmacovigilance Software Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmacovigilance Software Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmacovigilance Software Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacovigilance Software Market Size (2019-2030)
9.2 Latin America Pharmacovigilance Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmacovigilance Software Market Size by Country (2019-2024)
9.4 Latin America Pharmacovigilance Software Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacovigilance Software Market Size (2019-2030)
10.2 Middle East & Africa Pharmacovigilance Software Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmacovigilance Software Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmacovigilance Software Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 United BioSource Corporation
11.1.1 United BioSource Corporation Company Detail
11.1.2 United BioSource Corporation Business Overview
11.1.3 United BioSource Corporation Pharmacovigilance Software Introduction
11.1.4 United BioSource Corporation Revenue in Pharmacovigilance Software Business (2019-2024)
11.1.5 United BioSource Corporation Recent Development
11.2 Sparta Systems
11.2.1 Sparta Systems Company Detail
11.2.2 Sparta Systems Business Overview
11.2.3 Sparta Systems Pharmacovigilance Software Introduction
11.2.4 Sparta Systems Revenue in Pharmacovigilance Software Business (2019-2024)
11.2.5 Sparta Systems Recent Development
11.3 Oracle Corporation
11.3.1 Oracle Corporation Company Detail
11.3.2 Oracle Corporation Business Overview
11.3.3 Oracle Corporation Pharmacovigilance Software Introduction
11.3.4 Oracle Corporation Revenue in Pharmacovigilance Software Business (2019-2024)
11.3.5 Oracle Corporation Recent Development
11.4 Ennov Solutions
11.4.1 Ennov Solutions Company Detail
11.4.2 Ennov Solutions Business Overview
11.4.3 Ennov Solutions Pharmacovigilance Software Introduction
11.4.4 Ennov Solutions Revenue in Pharmacovigilance Software Business (2019-2024)
11.4.5 Ennov Solutions Recent Development
11.5 Max Application
11.5.1 Max Application Company Detail
11.5.2 Max Application Business Overview
11.5.3 Max Application Pharmacovigilance Software Introduction
11.5.4 Max Application Revenue in Pharmacovigilance Software Business (2019-2024)
11.5.5 Max Application Recent Development
11.6 EXTEDO GmbH
11.6.1 EXTEDO GmbH Company Detail
11.6.2 EXTEDO GmbH Business Overview
11.6.3 EXTEDO GmbH Pharmacovigilance Software Introduction
11.6.4 EXTEDO GmbH Revenue in Pharmacovigilance Software Business (2019-2024)
11.6.5 EXTEDO GmbH Recent Development
11.7 AB Cube
11.7.1 AB Cube Company Detail
11.7.2 AB Cube Business Overview
11.7.3 AB Cube Pharmacovigilance Software Introduction
11.7.4 AB Cube Revenue in Pharmacovigilance Software Business (2019-2024)
11.7.5 AB Cube Recent Development
11.8 Relsys
11.8.1 Relsys Company Detail
11.8.2 Relsys Business Overview
11.8.3 Relsys Pharmacovigilance Software Introduction
11.8.4 Relsys Revenue in Pharmacovigilance Software Business (2019-2024)
11.8.5 Relsys Recent Development
11.9 Online Business Applications
11.9.1 Online Business Applications Company Detail
11.9.2 Online Business Applications Business Overview
11.9.3 Online Business Applications Pharmacovigilance Software Introduction
11.9.4 Online Business Applications Revenue in Pharmacovigilance Software Business (2019-2024)
11.9.5 Online Business Applications Recent Development
11.10 ArisGlobal
11.10.1 ArisGlobal Company Detail
11.10.2 ArisGlobal Business Overview
11.10.3 ArisGlobal Pharmacovigilance Software Introduction
11.10.4 ArisGlobal Revenue in Pharmacovigilance Software Business (2019-2024)
11.10.5 ArisGlobal Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest IT & Electronics Market Reports

Global Refrigerator Camera Market Research Report, 2020-2031

Global Postal Automation System Market - Industry Trends and Forecast to 2031

Global 5G V2X Communications Market Research Report 2024

Global Cloud Fax Solution Market Research Report 2024

Global Leather Goods Repair Services Market Research Report 2024

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}